JNJ - SEC Form 4 insider transactions

SEC Form 4 filed by Director Woods Eugene A.

SEC Form 4 filed by Director West Nadja

SEC Form 4 filed by Director Weinberger Mark A

SEC Form 4 filed by Director Pinto Daniel E

SEC Form 4 filed by Director Morikis John G

SEC Form 4 filed by Director Mcclellan Mark B.

SEC Form 4 filed by Director Joly Hubert

SEC Form 4 filed by Director Johnson Paula A

SEC Form 4 filed by Director Hewson Marillyn A

SEC Form 4 filed by Director Doudna Jennifer A

SEC Form 4 filed by Director Beckerle Mary C

SEC Form 4 filed by Director Hewson Marillyn A

SEC Form 4 filed by Director Pinto Daniel E

SEC Form 4 filed by Director Woods Eugene A.

VP Corporate Controller Decker Robert J exercised 4,075 shares at a strike of $115.67 and sold $1,010,070 worth of shares (4,075 units at $247.87) (SEC Form 4)

EVP, WW Chair, MedTech Schmid Timothy sold $324,763 worth of shares (1,322 units at $245.66), decreasing direct ownership by 5% to 25,447 units (SEC Form 4)

EVP, CIO Swanson James D. sold $15,109,759 worth of shares (62,080 units at $243.39), exercised 73,140 shares at a strike of $139.50 and covered exercise/tax liability with 4,213 shares, increasing direct ownership by 36% to 25,698 units (SEC Form 4)

EVP, Chief TO and Risk Officer Wengel Kathryn E covered exercise/tax liability with 7,266 shares and converted options into 15,598 shares, increasing direct ownership by 8% to 114,288 units (SEC Form 4)

EVP, Chief HR Officer Mulholland Kristen converted options into 5,006 shares and covered exercise/tax liability with 1,585 shares, increasing direct ownership by 21% to 19,830 units (SEC Form 4)

Exec VP, CFO Wolk Joseph J exercised 107,784 shares at a strike of $76.02, covered exercise/tax liability with 18,130 shares and sold $21,767,827 worth of shares (89,654 units at $242.80) (SEC Form 4)

EVP, Innovative Medicine, R&D Reed John C exercised 54,844 shares at a strike of $147.75, covered exercise/tax liability with 913 shares and sold $13,105,233 worth of shares (53,931 units at $243.00) (SEC Form 4)

VP Corporate Controller Decker Robert J converted options into 3,736 shares and covered exercise/tax liability with 1,055 shares, increasing direct ownership by 13% to 23,682 units (SEC Form 4)

EVP, Chief Legal Officer Forminard Elizabeth converted options into 16,381 shares and covered exercise/tax liability with 8,361 shares, increasing direct ownership by 52% to 23,568 units (SEC Form 4)

EVP, WW Chair, MedTech Schmid Timothy exercised 29,554 shares at a strike of $92.76, covered exercise/tax liability with 2,287 shares and sold $5,527,506 worth of shares (22,623 units at $244.33), increasing direct ownership by 21% to 26,769 units (SEC Form 4)

EVP, WWC. Innovative Medicine Taubert Jennifer L converted options into 32,155 shares and covered exercise/tax liability with 15,717 shares, increasing direct ownership by 9% to 194,451 units (SEC Form 4)

CEO and Chairman of the Board Duato Joaquin converted options into 84,710 shares and covered exercise/tax liability with 36,230 shares, increasing direct ownership by 18% to 324,447 units (SEC Form 4)

EVP, Global Corp Affairs Broadhurst Vanessa converted options into 10,020 shares, covered exercise/tax liability with 4,414 shares and sold $1,508,288 worth of shares (6,197 units at $243.39), decreasing direct ownership by 3% to 23,003 units (SEC Form 4)

SEC Form 4 filed by Exec VP, CFO Wolk Joseph J

SEC Form 4 filed by EVP, WWC. Innovative Medicine Taubert Jennifer L

SEC Form 4 filed by EVP, CIO Swanson James D.

SEC Form 4 filed by EVP, WW Chair, MedTech Schmid Timothy

SEC Form 4 filed by EVP, Chief HR Officer Mulholland Kristen

SEC Form 4 filed by EVP, Chief Legal Officer Forminard Elizabeth

SEC Form 4 filed by CEO and Chairman of the Board Duato Joaquin

SEC Form 4 filed by VP Corporate Controller Decker Robert J

SEC Form 4 filed by EVP, Chief TO and Risk Officer Wengel Kathryn E

SEC Form 4 filed by EVP, Global Corp Affairs Broadhurst Vanessa

EVP, WW Chair, MedTech Schmid Timothy exercised 15,571 shares at a strike of $101.87 and covered exercise/tax liability with 10,335 shares, increasing direct ownership by 31% to 22,125 units (SEC Form 4)

EVP, Chief HR Officer Mulholland Kristen covered exercise/tax liability with 3,335 shares and exercised 5,625 shares at a strike of $101.87, increasing direct ownership by 16% to 16,409 units (SEC Form 4)

EVP, Chief TO and Risk Officer Wengel Kathryn E covered exercise/tax liability with 27,270 shares and exercised 38,945 shares at a strike of $101.87, increasing direct ownership by 12% to 105,956 units (SEC Form 4)

EVP, Chief Legal Officer Forminard Elizabeth exercised 8,921 shares at a strike of $129.51 and covered exercise/tax liability with 6,226 shares, increasing direct ownership by 21% to 15,548 units (SEC Form 4)

CEO and Chairman of the Board Duato Joaquin sold $22,122,893 worth of shares (100,000 units at $221.23) (SEC Form 4)

SEC Form 4 filed by Director Woods Eugene A.

SEC Form 4 filed by Director Hewson Marillyn A

SEC Form 4 filed by Director Pinto Daniel E

SEC Form 4 filed by Johnson & Johnson

Large owner Johnson & Johnson sold $27,132 worth of shares (2,700 units at $10.05) (SEC Form 4)

EVP, Innovative Medicine, R&D Reed John C exercised 21,721 shares at a strike of $157.92 and sold $4,185,793 worth of shares (21,721 units at $192.71) (SEC Form 4)

SEC Form 4 filed by Director Hewson Marillyn A

SEC Form 4 filed by Director Pinto Daniel E

SEC Form 4 filed by Director Woods Eugene A.

EVP, WWC. Innovative Medicine Taubert Jennifer L exercised 56,471 shares at a strike of $101.87 and sold $10,040,883 worth of shares (56,471 units at $177.81) (SEC Form 4)

Executive VP, General Counsel Forminard Elizabeth exercised 11,521 shares at a strike of $115.67 and covered exercise/tax liability with 9,570 shares, increasing direct ownership by 18% to 12,853 units (SEC Form 4)

CEO and Chairman of the Board Duato Joaquin exercised 125,824 shares at a strike of $101.87 and sold $22,548,655 worth of shares (125,824 units at $179.21) (SEC Form 4)

Exec VP, CFO Wolk Joseph J exercised 16,820 shares at a strike of $101.87 and sold $2,975,571 worth of shares (16,820 units at $176.91) (SEC Form 4)

EVP, Innovative Medicine, R&D Reed John C sold $3,129,830 worth of shares (19,137 units at $163.55), decreasing direct ownership by 64% to 10,658 units (SEC Form 4)

SEC Form 4 filed by Director Hewson Marillyn A

SEC Form 4 filed by Director Woods Eugene A.

EVP, Innovative Medicine, R&D Reed John C converted options into 25,255 shares and covered exercise/tax liability with 11,002 shares, increasing direct ownership by 92% to 29,795 units (SEC Form 4)

SEC Form 4 filed by Director Woods Eugene A.